4th Quarter - Report
S-3 GROUP for AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC.
Firm
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Foreign entity interest: Issues listed in Line 16 directly affect the business interests of Horizon Pharma PLC.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN CASEY | Senior Pol Dir, Dem Caucus; Counselor, Leg. Dir, Leg. Asst, Rep. Joseph Crowley; Staff Asst, Leg. Correspondent, Rep. Bob Weygand |
| MICHAELEEN EARLE CROWELL | Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders |
| OLIVIA KURTZ | Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle |
| MARTIN REISER | Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.